Trial intelligence / Profile preview

Prazosin for Alcohol Dependence

NCT00167687Phase 4Completed

Sponsor
University of Washington
Start
Sep 2005
Primary completion
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in alcohol dependence comparing Prazosin with Placebo (2 arms). Primary endpoints: Number of days drinking during the six week intervention at 6 weeks and Number of drinks per drinking day consumed at 6 weeks. Started Sep 2005; status: completed.

02

Drugs

prazosin
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT00167687.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00167687.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call